Ilya Rachman, M.D., Ph.D., MBA, is the co-founder and CEO of Immix Biopharma, a NASDAQ-listed clinical-stage biopharmaceutical company developing targeted.
Ilya Rachman, M.D., Ph.D., MBA, is the co-founder and CEO of Immix Biopharma, a NASDAQ-listed clinical-stage biopharmaceutical company developing targeted nanodrug combinations for resistant cancers. He is a physician-scientist leading the company's pipeline of Tissue-Specific Therapeutics (TSTx) in oncology and inflammation, with lead asset IMX-110 in Phase 1b/2a trials for solid tumors.
Full founder directory · Investor directory · Company funding database · Fundraising library